| | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
---|
|
|
| | | | CM | Angomed | 50 | PR | PR | k.A. | | Coated tablets: 2 Active Agents | Zeller Medical AG | D | FB | | G |  |
| | | | CM | Angomed | 100 | PR | PR | k.A. | | Coated tablets: 2 Active Agents | Zeller Medical AG | D | FB | | G |  |
| | | | CM | Angomed | 200 | PR | PR | k.A. | | Coated tablets: 2 Active Agents | Zeller Medical AG | D | FB | | G |  |
| | | | | Apixaban axapharm 2.5 mg | 20 | PR | PR | k.A. | | Coated tablets: Apixabanum 2.5 mg | axapharm ag | B | FB | | G |  |
| | | | | Apixaban axapharm 2.5 mg | 56 | PR | PR | k.A. | | Coated tablets: Apixabanum 2.5 mg | axapharm ag | B | FB | | G |  |
| | | | | Apixaban axapharm 2.5 mg | 100 | PR | PR | k.A. | | Coated tablets: Apixabanum 2.5 mg | axapharm ag | B | FB | | G |  |
| | | | | Apixaban axapharm 2.5 mg | 168 | PR | PR | k.A. | | Coated tablets: Apixabanum 2.5 mg | axapharm ag | B | FB | | G |  |
| | | | | Apixaban axapharm 5 mg | 56 | PR | PR | k.A. | | Coated tablets: Apixabanum 5 mg | axapharm ag | B | FB | | G |  |
| | | | | Apixaban axapharm 5 mg | 100 | PR | PR | k.A. | | Coated tablets: Apixabanum 5 mg | axapharm ag | B | FB | | G |  |
| | | | | Apixaban axapharm 5 mg | 168 | PR | PR | k.A. | | Coated tablets: Apixabanum 5 mg | axapharm ag | B | FB | | G |  |
| | | | | Beroseren | 40 | PR | PR | k.A. | | | Bayer (Schweiz) AG | D | FB | | G |  |
| | | | | Beroseren | 120 | PR | PR | k.A. | | | Bayer (Schweiz) AG | D | FB | | G |  |
| | | | | Beroseren | 180 | PR | PR | k.A. | | | Bayer (Schweiz) AG | D | FB | | G |  |
| | | | | Carbetocin Aguettant 100 μg/mL | 5 | PR | PR | k.A. | | solution injectable en seringue préremplie: Carbetocinum 100 µg | Aguettant Suisse SA | A | FB | | G |  |
| | | | CM | Coop Vitality Pantoprazol 20 mg | 14 | PR | PR | k.A. | | Gastric juice resistant tablets: Pantoprazolum 20 mg | Coop Vitality Health Care GmbH | D | FB | | G |  |
| | | | | Dapagliflozin-Mepha 10 mg | 28 | PR | PR | k.A. | | Coated tablets: Dapagliflozinum 10 mg | Mepha Pharma AG | B | FB | | G |  |
| | | | | Dapagliflozin-Mepha 10 mg | 98 | PR | PR | k.A. | | Coated tablets: Dapagliflozinum 10 mg | Mepha Pharma AG | B | FB | | G |  |
| | | | | Dapagliflozin-Mepha 5 mg | 28 | PR | PR | k.A. | | Coated tablets: Dapagliflozinum 5 mg | Mepha Pharma AG | B | FB | | G |  |
| | | | | Dapagliflozin-Mepha 5 mg | 98 | PR | PR | k.A. | | Coated tablets: Dapagliflozinum 5 mg | Mepha Pharma AG | B | FB | | G |  |
| | | | V/S | Efluelda TIV 0.5 mL | | PR | PR | k.A. | | suspension injectable en seringue pré-remplie: 3 Active Agents | Sanofi-Aventis (Suisse) SA | B | FB | | G |  |
| | | | V/S | Efluelda TIV 0.5 mL | 10 | PR | PR | k.A. | | suspension injectable en seringue pré-remplie: 3 Active Agents | Sanofi-Aventis (Suisse) SA | B | FB | | G |  |
| | IP | | | Fluticason Leman 27.5 ug | 120 | PR | PR | k.A. | | | Leman SKL SA | B | FB | | G |  |
| | | | CM | Hydromorphone Mundipharma 10 mg | 5 | PR | PR | k.A. | | Infusion solution: Hydromorphoni Hydrochloridum 10 mg/ml | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ | FB | | G |  |
| | | | CM | Hydromorphone Mundipharma 10 mg | 10 | PR | PR | k.A. | | Infusion solution: Hydromorphoni Hydrochloridum 10 mg/ml | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ | FB | | G |  |
| | | | CM | Hydromorphone Mundipharma 2 mg | 5 | PR | PR | k.A. | | Infusion solution: Hydromorphoni Hydrochloridum 2 mg/ml | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ | FB | | G |  |
| | | | CM | Hydromorphone Mundipharma 2 mg | 10 | PR | PR | k.A. | | Infusion solution: Hydromorphoni Hydrochloridum 2 mg/ml | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ | FB | | G |  |
| | | | CM | Hydromorphone Mundipharma 20 mg | 5 | PR | PR | k.A. | | Infusion solution: Hydromorphoni Hydrochloridum 20 mg/ml | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ | FB | | G |  |
| | | | CM | Hydromorphone Mundipharma 20 mg | 10 | PR | PR | k.A. | | Infusion solution: Hydromorphoni Hydrochloridum 20 mg/ml | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ | FB | | G |  |
| | | | CM | Hydromorphone Mundipharma 50 mg | 5 | PR | PR | k.A. | | Infusion solution: Hydromorphoni Hydrochloridum 50 mg/ml | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ | FB | | G |  |
| | | | CM | Hydromorphone Mundipharma 50 mg | 10 | PR | PR | k.A. | | Infusion solution: Hydromorphoni Hydrochloridum 50 mg/ml | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ | FB | | G |  |
| | IP | | | Hylvastam 14 mg/ml | 12 x 250 ml | PR | PR | k.A. | | Infusion solution: 2 Active Agents | Leman SKL SA | B | FB | | G |  |
| | IP | | | Hylvastam 14 mg/ml | 12 x 250 ml | PR | PR | k.A. | | Infusion solution: 2 Active Agents | Leman SKL SA | B | FB | | G |  |
| | IP | | | Hylvastam 14 mg/ml | 12 x 500 ml | PR | PR | k.A. | | Infusion solution: 2 Active Agents | Leman SKL SA | B | FB | | G |  |
| | IP | | | Hylvastam 14 mg/ml | 12 x 500 ml | PR | PR | k.A. | | Infusion solution: 2 Active Agents | Leman SKL SA | B | FB | | G |  |
| | | | | Imatinib Spirig HC 100 mg | 60 | PR | PR | k.A. | | Coated tablets: Imatinibum 100 mg | Spirig HealthCare AG | A | FB | | G |  |
| | | | | Imatinib Spirig HC 400 mg | 30 | PR | PR | k.A. | | Coated tablets: Imatinibum 400 mg | Spirig HealthCare AG | A | FB | | G |  |
| | | | | Metronidazole Lagap iv 500mg/100ml | 10 x 100 ml | PR | PR | k.A. | | soluzione per infusione: Metronidazolum 500mg / 100ml | Lagap SA | B | FB | | G |  |
| | | | | Metronidazole Lagap iv 500mg/100ml | 25 x 100 ml | PR | PR | k.A. | | soluzione per infusione: Metronidazolum 500mg / 100ml | Lagap SA | B | FB | | G |  |
| | | | | Metronidazole Lagap iv 500mg/100ml | 50 x 100 ml | PR | PR | k.A. | | soluzione per infusione: Metronidazolum 500mg / 100ml | Lagap SA | B | FB | | G |  |
| | IP | | V/S | mResvia Respiratorisches- Synzytial-Virus (RSV) Vakzin 0.10 mg/ml | | PR | PR | k.A. | | | Moderna Switzerland GmbH | B | FB | | G |  |
| | IP | | V/S | mResvia Respiratorisches- Synzytial-Virus (RSV) Vakzin 0.10 mg/ml | 10 | PR | PR | k.A. | | | Moderna Switzerland GmbH | B | FB | | G |  |
| | | | | Nexpovio 20 mg | 8 | PR | PR | k.A. | | Coated tablets: Selinexorum 20 mg | Stemline Therapeutics Switzerland GmbH | A | FB | | G |  |
| | | | | Nexpovio 20 mg | 12 | PR | PR | k.A. | | Coated tablets: Selinexorum 20 mg | Stemline Therapeutics Switzerland GmbH | A | FB | | G |  |
| | | | | Nexpovio 20 mg | 16 | PR | PR | k.A. | | Coated tablets: Selinexorum 20 mg | Stemline Therapeutics Switzerland GmbH | A | FB | | G |  |
| | | | | Nexpovio 20 mg | 20 | PR | PR | k.A. | | Coated tablets: Selinexorum 20 mg | Stemline Therapeutics Switzerland GmbH | A | FB | | G |  |
| | | | | Nexpovio 20 mg | 32 | PR | PR | k.A. | | Coated tablets: Selinexorum 20 mg | Stemline Therapeutics Switzerland GmbH | A | FB | | G |  |
| | | | | Nilotinib Spirig HC 150 mg | 112 | PR | PR | k.A. | | Capsules: Nilotinibum 150 mg | Spirig HealthCare AG | A | FB | | G |  |
| | | | | Nilotinib Spirig HC 200 mg | 28 | PR | PR | k.A. | | Capsules: Nilotinibum 200 mg | Spirig HealthCare AG | A | FB | | G |  |
| | | | | Nilotinib Spirig HC 200 mg | 112 | PR | PR | k.A. | | Capsules: Nilotinibum 200 mg | Spirig HealthCare AG | A | FB | | G |  |
| | | | | Nilotinib Spirig HC 50 mg | 120 | PR | PR | k.A. | | Capsules: Nilotinibum 50 mg | Spirig HealthCare AG | A | FB | | G |  |
| | | | CM | Pantofelan 20 mg | 14 | PR | PR | k.A. | | Gastric juice resistant tablets: Pantoprazolum 20 mg | G-Pharma AG | D | FB | | G |  |
| | | | | Pomalidomid Accord 1 mg | 21 | PR | PR | k.A. | | Capsules: Pomalidomidum 1 mg | Accord Healthcare AG | A | FB | | G |  |
| | | | | Pomalidomid Accord 2 mg | 21 | PR | PR | k.A. | | Capsules: Pomalidomidum 2 mg | Accord Healthcare AG | A | FB | | G |  |
| | | | | Pomalidomid Accord 3 mg | 21 | PR | PR | k.A. | | Capsules: Pomalidomidum 3 mg | Accord Healthcare AG | A | FB | | G |  |
| | | | | Pomalidomid Accord 4 mg | 21 | PR | PR | k.A. | | Capsules: Pomalidomidum 4 mg | Accord Healthcare AG | A | FB | | G |  |
| | | | | Protaminsulfat LEO Pharma 1400 Heparin-Antidot I.E./ml | 5 x 5 ml | PR | PR | k.A. | | Injektionslösung und Infusionslösung: Protamini Sulfas 1400 UI/ml | LEO Pharmaceutical Products Sarath Ltd. | B | FB | | G |  |
| | | | | Pylclari 1000 MBq/ml | 1 ml | PR | PR | k.A. | | Injection solution: Piflufolastatum(18-f) 1000 MBq/ml | b.e.imaging.ag | A | FB | | G |  |
| | | | | Pylclari 1500 MBq/ml | 1 ml | PR | PR | k.A. | | Injection solution: Piflufolastatum(18-f) 1500 MBq/ml | b.e.imaging.ag | A | FB | | G |  |
| | | | | Remicade 100 mg | | PR | PR | k.A. | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Infliximabum 100 mg | Pharma Nova GmbH | A | FB | | G |  |
| | | | | Rosuvastax-Drossapharm 10 mg | 30 | PR | PR | k.A. | | Coated tablets: Rosuvastatinum 10 mg | Drossapharm AG | B | FB | | G |  |
| | | | | Rosuvastax-Drossapharm 10 mg | 100 | PR | PR | k.A. | | Coated tablets: Rosuvastatinum 10 mg | Drossapharm AG | B | FB | | G |  |
| | | | | Rosuvastax-Drossapharm 20 mg | 30 | PR | PR | k.A. | | Coated tablets: Rosuvastatinum 20 mg | Drossapharm AG | B | FB | | G |  |
| | | | | Rosuvastax-Drossapharm 20 mg | 100 | PR | PR | k.A. | | Coated tablets: Rosuvastatinum 20 mg | Drossapharm AG | B | FB | | G |  |
| | | | | Rosuvastax-Drossapharm 5 mg | 30 | PR | PR | k.A. | | Coated tablets: Rosuvastatinum 5 mg | Drossapharm AG | B | FB | | G |  |
| | | | | Rosuvastax-Drossapharm 5 mg | 100 | PR | PR | k.A. | | Coated tablets: Rosuvastatinum 5 mg | Drossapharm AG | B | FB | | G |  |
| | | | | Steqeyma 130mg / 26mL | | PR | PR | k.A. | | Concentrate for infusion: Ustekinumabum 130mg / 26ml | iQone Healthcare Switzerland SA | B | FB | | G |  |
| | | | | Steqeyma 45mg / 0.5mL | | PR | PR | k.A. | | solution injectable en seringue préremplie: Ustekinumabum 45mg / 0.5ml | iQone Healthcare Switzerland SA | B | FB | | G |  |
| | | | | Steqeyma 90mg / 1.0mL | | PR | PR | k.A. | | solution injectable en seringue préremplie: Ustekinumabum 90 mg/ml | iQone Healthcare Switzerland SA | B | FB | | G |  |
| | IP | | | Teicoplanin-Evultis 200 mg | 5 | PR | PR | k.A. | | Polvere per soluzione iniettabile/per infusione o soluzione orale: Teicoplaninum 200 mg | Evultis SA | A | FB | | G |  |
| | IP | | | Teicoplanin-Evultis 200 mg | 10 | PR | PR | k.A. | | Polvere per soluzione iniettabile/per infusione o soluzione orale: Teicoplaninum 200 mg | Evultis SA | A | FB | | G |  |
| | IP | | | Teicoplanin-Evultis 400 mg | 5 | PR | PR | k.A. | | Polvere per soluzione iniettabile/per infusione o soluzione orale: Teicoplaninum 400 mg | Evultis SA | A | FB | | G |  |
| | IP | | | Teicoplanin-Evultis 400 mg | 10 | PR | PR | k.A. | | Polvere per soluzione iniettabile/per infusione o soluzione orale: Teicoplaninum 400 mg | Evultis SA | A | FB | | G |  |
| | | | | Tepezza 500 mg | | PR | PR | k.A. | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Teprotumumabum 500 mg | Amgen Switzerland AG | A | FB | | G |  |
| | | | | Viburcol | 50 | PR | PR | k.A. | | Tablets: 6 Active Agents | ebi-pharm ag | D | FB | | G |  |